Observational studyWorld journal of gastroenterology2020

Rifaximin improves survival in cirrhotic patients with refractory ascites: A real-world study.

Xin-Yue Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.